A VALIDATED RP-HPLC METHOD FOR IMPURITY PROFILING OF SODIUM NITROPRUSSIDE IN INJECTION DOSAGE FORM by P., MURALI KRISHNAM RAJU et al.
Original Article 
A VALIDATED RP-HPLC METHOD FOR IMPURITY PROFILING OF SODIUM NITROPRUSSIDE IN 
INJECTION DOSAGE FORM 
 
MURALI KRISHNAM RAJU P.a,b, VENKATA NARAYANA B.b, SHYAMALA P.a*, SRINIVASU KONDRAb, HSN RAJU 
DANTULURIb 
aDepartment of Physical, Nuclear Chemistry and Chemical Oceanography, School of Chemistry, Andhra University, Visakhapatnam 
530003, Andhra Pradesh, India, bAurobindo Pharma Limited, Bachupally, R. R District, Hyderabad 500090, Telangana, India 
Email: shyamalapulipaka06@gmail.com 
Received: 25 Aug 2020, Revised and Accepted: 08 Oct 2020 
ABSTRACT 
Objective: The main objective of this research work is to develop and validate a single reverse-phase high-performance liquid chromatography (RP-
HPLC) method. This method should be capable of quantifying all the known, as well as other possible degradation impurities of sodium 
nitroprusside (SNP) in its injection formulation. 
Methods: Of all method development trails, we have observed better separations between known and degradation impurities in Inert sustain C18, 
(250 x 4.6) mm, 5 µm column at 30 °C temperature. Isocratic elution was carried out by using pH 8.6 phosphate buffer and acetonitrile in the ratio of 
65:35 %v/v with a flow rate of 0.8 ml/min. The detection was carried out at 220 nm, with an injection volume of 10 µl. 
Results: In the proposed method, SNP was eluted at 22.5 min. Nitrite, nitrate, and ferrocyanide were linear from 0.25 to 37 μg/ml, ferricyanide was 
linear from 1.0 to 37 μg/ml, and SNP was linear from 0.75 to 37 μg/ml. The % RSD for six spiked samples (precision) was found to be less than 0.5 
%. Accuracy was performed for known impurities from LOQ to 150 % for a 0.5 % specification level. The results were found to be in the acceptance 
range of 90-110 %. The LOQ concentration of nitrite, nitrate, and ferrocyanide was 0.25 μg/ml each, LOQ of ferricyanide and SNP was found to be 
1.0 μg/ml and 0.75 μg/ml, respectively. The SNP injection samples were exposed to different degradation conditions, and the results were found 
specific in the proposed methodology. 
Conclusion: The proposed RP-HPLC method is specific, precise, accurate, linear, stable, and robust for quantification of known and other possible 
degradation impurities in SNP injection formulation. 
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© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
DOI: http://dx.doi.org/10.22159/ijap.2021v13i1.39534. Journal homepage: https://innovareacademics.in/journals/index.php/ijap  
 
INTRODUCTION 
SNP is a sodium salt of di anionic metal complex dihydrate with 
molecular formula Na2[Fe(CN)5NO].2H2O. It is chemically named 
as Ferrate (2-), pentakis(cyano-C)nitrosyl-, disodium, dihydrate [1, 
2]. It is a potent rapid-acting hypotensive agent and when 
administered intravenously. SNP is used to lower blood pressure 
during surgical operations. Continuous injection of SNP might cause 
cyanide poisoning; therefore, intravenous administration rate (10 
mcg/kg/min) is strictly controlled [3, 4]. However, there are several 
problems associated with the clinical use of sodium nitroprusside, 
including tolerance and the toxicity of its metabolites, cyanide, and 
thiocyanate [5, 6]. 
The literature survey of SNP revealed some of the reported 
pharmacopeia methods for the estimation of ferricyanide and 
ferrocyanide in SNP [7, 8]. The reported HPLC methods were found for 
estimation of nitrates and nitrites [9, 10]. A HPLC method was proposed 
for the estimation of ferrocyanide in food-grade salts [11]. A 
spectrophotometric method was published for the estimation of SNP and 
its photo degradants [12]. An assay by HPLC method was reported for 
SNP [13], and an in vitro stability of SNP for intravenous administration 
methodology was reported [14]. Based on the literature survey, it was 
observed that most of the reported works concentrated on the assay of 
SNP, the content of ferricyanide, and ferrocyanide in SNP. To date, no 
analytical method was published to quantify all known and possible 
degradation impurities of SNP simultaneously in the single liquid 
chromatography (LC) method for injection formulation. 
Taking cues from literature, we have decided to develop and validate 
a short RP-HPLC method for detecting all possible impurities of SNP 
in injection formulation. During development, we have performed 
several stress conditions such as hydrolysis, oxidation, photolysis 
and thermal conditions in order to highlight the possible 
degradation impurities in the proposed methodology [15-17]. The 
developed method was checked for specificity, precision, linearity, 
accuracy, robustness and stability of solutions based on ICH Q2 (R1) 
[18]. Based on method development and validation results, the 
proposed LC method could quantify all known and other possible 
degradation impurities. The chemical structures of four known 
impurities and SNP are given in fig. 1. 
MATERIALS AND METHODS  
Chemicals 
SNP standard and injection formulation (labelled 25 mg/ml) 
samples were provided by Aurobindo pharma research center-1, 
Hyderabad, Telangana, India. Impurities, sodium nitrite USP 
reference standard and sodium nitrate USP reference standards 
were procured from the United States pharmacopeial convention, 
USA. Potassium ferrocyanide trihydrate and potassium ferricyanide 
procured from Sigma Aldrich, USA. Chemicals, such as Di-sodium 
hydrogen phosphate (ACS), orthophosphoric acid (AR), sodium 
hydroxide (AR), hydrogen peroxide (LR), and acetonitrile (HPLC) 
were procured from Merck, India. HPLC grade water and 
Hydrochloric acid (AR) were procured from Rankem, India. Tetra-n-
butylammonium hydroxide 40% solution in water was procured 
from Alfa aesar, UK. 
Instrumentation  
This research work was carried out on Shimadzu prominence HPLC 
(LC-20AD), consisting of a quaternary solvent manager and an 
online degasser unit (DGU-20A5R). This instrument is equipped 
with a photodiode array detector (SPD-M20A), it operates and data 
processes with waters empower 3 software. Waters Alliance e2695 
separations module HPLC with a quaternary solvent delivery system 
and an online degasser unit. This instrument is equipped with a 
photodiode array detector (SPD-M20A), it operates and data 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 13, Issue 1, 2021 
Shyamala et al. 
Int J App Pharm, Vol 13, Issue 1, 2021, 160-169 
161 
processes with waters empower 3 software. Other instruments used 
in this research include Sartorius make Microbalance (SE2), 
Sartorius make Analytical balance (CPA225D), Eutech make pH 
meter (pH 2700), Cintex make Water bath (CIC-2BM) and Borosil 




Fig. 1: Chemical structures of ferricyanide, ferrocyanide, nitrate, nitrite and SNP 
  
Chromatographic conditions 
Optimum results were obtained in isocratic mode using a mobile 
phase containing a degassed mixture of disodium hydrogen 
phosphate dihydrate (25 mmol), 13 ml/l of Tetra-n-butylammonium 
hydroxide 40% solution in water [19], pH adjusted to 8.6 with 
orthophosphoric acid and acetonitrile in the ratio of 65:35 %v/v 
[19]. Other chromatographic conditions include Column: 
Inertsustain C18 (250×4.6 mm, 5 μm) (make: GL Sciences) [19], 
Column temperature: 30 °C, Flow rate: 0.8 ml/min [20], Injection 
volume: 10 µl [20] at Detector wavelength: 220 nm. The mobile 
phase, standard, and sample solution were filtered through a 0.45 
μm membrane filter before injecting it into the HPLC system. 
Diluent preparation 
Mobile phase was used as diluent. 
Preparation of standard stock-1: (1000 µg/ml) 
Accurately transferred 38 mg of sodium nitrite, 41 mg of 
potassium nitrate, 50 mg of potassium ferrocyanide trihydrate and 
25 mg of SNP standard into a 25 ml volumetric flask containing 10 
ml of diluent, dissolved and made up to the mark with diluent, 
mixed well. 
Preparation of standard stock-2: (1000 µg/ml) 
Accurately transferred 39 mg of potassium ferricyanide standard in 
to a 25 ml volumetric flask containing 10 ml of diluent, dissolved and 
made up to the mark with diluent, mixed well. 
Preparation of standard solution-1: (10 µg/ml) 
Accurately transferred 1 ml of standard stock-1 into a 100 ml 
volumetric flask, made up to the mark with diluent and mixed well.  
Preparation of standard solution-2: (10 µg/ml) 
Accurately transferred 1 ml of standard stock-2 into a 100 ml 
volumetric flask, made up to mark with diluent and mixed well.  
Preparation of sample solution: (5000 µg/ml) 
Pooled sample was prepared by mixing the contents of 3 vials of SNP 
injection formulation (fill volume: 2 ml each). Accurately transferred 
2 ml of pooled sample into a 10 ml volumetric flask, made up to 
mark with diluent and mixed well. 
RESULTS AND DISCUSSION 
Method development and optimization 
According to available pharmacopoeia monographs, titrimetric 
methods were used for the quantification of ferricyanide and 
ferrocyanide in SNP. These methods are only specific for 
quantification of ferricyanide and ferrocyanide, where other 
impurities cannot be quantified [21, 22]. In some articles, authors 
reported ferricyanide, ferrocyanide and other possible 
photodegradation impurities by using spectrophotometry in SNP 
[23, 24]. By some articles, authors reported A HPLC method for 
determining nitrate and nitrite levels in vegetables [25]. Till now, no 
reported article was published by addressing ferricyanide, 
ferrocyanide, nitrate, nitrite and other possible degradation 
impurities, likely to be formed during the product shelf life all 
together in a single chromatographic method. 
Taking cues from the available literature, we have taken it as a 
challenge to develop a short, stable, sensitive, accurate and robust, 
RP-HPLC method for detecting all possible impurities of the SNP 
with sensitivity less than 1 µg/ml. The SNP and their impurities are 
charged species and are highly polar. Hence conventional HPLC 
mobile phases and columns could not hold the polar components in 
reverse phase chromatography, as it leads to poor resolutions. To 
get adequate resolutions between the negatively charged 
components such as ferricyanide, ferrocyanide and SNP in an 
octadecylsilane bonded column (C18), basic ion pain reagent like 
tetrabutylammonium hydroxide (TBAH) was introduced into the 
mobile phase [26]. 
Along with TBAH, other basic ion-pair reagents are also available in 
the market, include tetraethylammonium hydroxide (TEAH) and 
tetramethylammonium hydroxide (TMAH) etc. As TBAH is available 
at our research laboratory, the same is used for the preparation of 
the mobile phase to hold the negatively charged species in the 
column. TBAH in the mobile phase could hold the negatively charged 
species by decreasing the charge to mass ratio. Due to the presence 
of basic ion pair reagent in the mobile phase, the hydrophobic 
property of negatively charged species increases, resulting in longer 
retention times. Based on the literature, the mobile backup phase 
was prepared at basic pH by using TBAH [26-28]. The development 
work was carried out in columns which could withstand basic 
mobile phase pH such as Gemini C18 (250×4.6 mm, 5 μm) make: 
Phenomenex, Inertsustain C18 (250×4.6 mm, 5 μm) (make: GL 
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Sciences), X-Bridge C18 (250×4.6 mm, 5 μm) (Make: Waters), Zorbax 
extend C18 (250 ×4.6 mm, 5 μm) (make: Agilent). Of all the 
mentioned columns, the optimum separation between the 
impurities was achieved in the Inertsustain C18 column with 
dimensions (250×4.6 mm, 5 μm) (make: GL Sciences). Along with 
columns, different mobile phase pH, compositions, column 
temperatures and flow rates were also evaluated. Some of the 
method development trials for mobile phase composition, pH and 
column oven temperature by keeping other chromatographic 
conditions constant were given in table 1. 
 
Table 1: Method development trials to improve the resolution between SNP related impurities 
Buffer pH Composition* Temp** ( °C) Observation 
6.0 58:42 40 °C Poor resolution between ferricyanide and SNP  
7.1 70:30 40 °C Poor resolution between ferrocyanide and unknown impurity. 
8.0 62:38 40 °C Resolution between ferricyanide and SNP was not satisfactory. 
8.0 65:35 40 °C Resolution between ferricyanide and SNP was not satisfactory. 
8.5 58:42 35 °C Resolution between ferrocyanide and unknown impurity was not satisfactory. 
8.5 58:42 40 °C Resolution between ferrocyanide and unknown impurity was not satisfactory. 
8.5 62:38 35 °C Resolution between ferricyanide and SNP was not satisfactory. 
8.5 60:40 35 °C Resolution between ferrocyanide and unknown impurity was not satisfactory. 
8.5 60:40 40 °C Resolution between ferrocyanide and unknown impurity was not satisfactory. 
8.6 65:35 30 °C Peak shapes and resolutions between all degradants found satisfactory. 
8.8 65:35 30 °C Peak shapes and resolutions between all degradants found satisfactory. 
*Mobile phase composition (Buffer: Acetonitrile) % v/v, **Column oven temperature 
 
Response factor calculation for both ferricyanide and 
ferrocyanide 
The percentage of known impurities were calculated against their 
corresponding standard solutions. Out of four known impurities, 
ferrocyanide and ferricyanide are readily interconvertible [Fe 
(CN)6]3−+e− ⇌ Fe (CN)6]4− [29]. During the stress study, it was 
observed that the presence of peroxides in diluent is facilitating the 
conversion of ferricyanide to ferrocyanide. Ferricyanide and 
ferrocyanide redox reaction could be controlled by purging the diluent 
with inert gas (Nitrogen/Helium) from the bottom of the flask to 
remove the residual oxygen. Even after taking such precautions, 
ferricyanide is slightly converting to ferrocyanide based on time. In 
addressing the issue of quantifying the known impurities and 
degradation impurities, two different standards were proposed. The first 
standard consists of nitrite, nitrate, ferrocyanide and SNP, whereas the 
second standard consists of ferricyanide. Actual areas of ferrocyanide 
and ferricyanide from both the standards even after slight 
interconversion were determined by using the response factor (RF). 
Ferricyanide easily converts to ferrocyanide in the presence of 
peroxides. Hence, RF for ferrocyanide and ferricyanide redox 
conversion was determined using area lost to the area gain by using 
2% hydrogen peroxide to facilitate the redox reaction. RF 
determination for ferrocyanide and ferricyanide redox conversion 
was given in table 2. 
 
Table 2: Determination of response factor for redox couple by using 2% hydrogen peroxide 
Degradation 
time* (h) 
Area from peroxide stress sample Response factor (RF) 
Ferricyanide Ferrocyanide Area of ferricyanide 
lost (A) 






0  5509424 458792 NA NA NA NA 
1  5468329 595608 41095 136816 3.33 0.30 
2  5417119 777561 92305 318769 3.45 0.29 
5  4987023 2065594 522401 1606802 3.08 0.33 
8  4392412 4234070 1117012 3775278 3.38 0.30 
12  3976131 5566206 1533293 5107414 3.33 0.30 
Average response factor  3.3 0.3 
*Ferricyanide degradation time after addition of 2% hydrogen peroxide, Actual area of ferrocyanide and ferricyanide from both the standard 
solutions were calculated with the help of RF. The details of the calculation were given in table 3.  
 
Table 3: Area calculations 
Calculation for determination of actual ferrocyanide area from standard-1 
A1 B1 RF1 (3.3) C1 = B1 x RF1 C1+A1 
Ferrocyanide 
area from standard-1 
 Ferricyanide area 
from standard-1  
Response factor [To convert area of 
ferricyanide (B1) to ferrocyanide (C1) 
Area of 
ferrocyanide lost 
Actual area of ferrocyanide 
from standard-1 
Calculation for determination of actual ferricyanide area from standard-2 
A2 B2 RF2 (0.3) C2 = B2 x RF2 C2+A2 
Ferricyanide 
area from standard-2 
 Ferrocyanide area 
from standard-2 
Response factor (To convert area of 
ferrocyanide (B2) to ferricyanide (C2) 
Area of ferricyanide 
lost 
Actual area of ferricyanide 
from standard-2 
 
System suitability  
The finalized related substances method was capable of quantifying 
all known and other possible degradation impurities in SNP 
injection formulation. As a part of the system suitability, two 
different standard solutions are adopted to find the exact areas of 
ferrocyanide and ferricyanide. 
Standard-1 contains 10 µg/ml of each nitrite, nitrate, 
ferrocyanide and SNP and Standard-2 contains 10 µg/ml of 
ferricyanide. Chromatograms of both standards were given in fig. 
2 and 3. 
System suitability results were calculated from both the standards to 
check the ability of the analytical instrument and method. The system 
suitability results from both the standards were given in table 4. 
System suitability results show the peak asymmetry, USP plate 
count, resolution between the closely eluting impurities nitrite and 
nitrate are meeting the acceptance criteria. 
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Fig. 2: Representative chromatogram of standard-1 containing nitrite, nitrate, ferrocyanide and SNP 
 
 
Fig. 3: Representative chromatogram of standard-2 containing ferricyanide and its redox counterpart ferrocyanide 
 
Table 4: System suitability results obtained from both standard-1 and 2 
S. No.  Components  RT*  RRT** Area Resolution# Peak asymmetry USP plate count 
1  Nitrite 3.92 0.17 598085 --- 1.2 11172 
2  Nitrate 4.71 0.21 414971 5.0 1.2 13163 
3  Ferrocyanide 8.76 0.39 668677 --- 1.1 9739 
4 Ferricyanide 18.74 0.83 172022 --- 1.2 15500 
5 SNP 22.49 1.00 237932 --- 1.1 18059 
*Retention time (min), **Relative retention time (RT of impurity/RT of SNP), #Resolution between closely eluting impurities nitrite and nitrate from 
standard-1 
 
Method validation  
The proposed LC method for quantification of known and other 
possible degradation impurities obtained during stress studies of 
SNP was validated as per ICH guidelines Q2 (R1). 
Specificity 
Specificity indicates the analytical method’s ability to distinguish 
accurately and specifically each analyte of interest in the presence of 
other components such as blank, placebo matrix and other possible 
impurity peaks related to SNP. 
The specificity experiment was conducted by injecting blank, 
individual impurities, and known impurity spiked samples in LC 
equipped with a photodiode array (PDA) detector to check the peak 
purity. The SNP injection formulation does not have any placebo 
matrix; hence placebo is not injected. Peak purity was calculated for 
known impurities and SNP from the spiked sample, and the data 
were given in table 5. Typical chromatograms of the blank, control 
sample and spiked sample were given in fig. 4-6 
Selectivity 
Selectivity indicates the ability of an analytical method to distinguish 
all possible degradation impurities that are going to be generated in 
any sample over a period of time. To make sure the method 
selectivity SNP injection was exposed to different stress conditions 
such as hydrolysis, thermal, oxidation and photolytic [30-32]. 
Degraded samples were chromatographed by using HPLC equipped 
with PDA detector to establish method selectivity. Chromatograms 
of these stress conditions were given in fig. 7-11. From these stress 
conditions, peak purity of the SNP was measured to make sure the 
co-elution of any degradation impurity. Peak purity results of the 
SNP from degraded samples were given in table 6. 
Acid degradation 
Into a 10 ml volumetric flask containing 2 ml of SNP injection, 1 ml of 1 
mol hydrochloric acid was added and the solution was kept at room 
temperature for 3 h. The degraded sample was neutralized with 1 ml of 
1 mol sodium hydroxide, made up to 10 ml mark with diluent and 
chromatographed. The resultant chromatogram was given in fig. 7. 
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Fig. 4: Blank chromatogram 
 
 
Fig. 5: Control sample chromatogram 
 
 
Fig. 6: Chromatogram of spiked sample with known impurities at 0.5% level (25 µg/ml) 
 
Table 5: Peak purity results of known impurities and SNP from spiked sample 
Component RT RRT Peak purity*  
Purity angle Purity threshold 
Nitrite 3.915 0.19 0.069 0.246 
Nitrate 4.689 0.23 0.051 0.265 
Ferrocyanide 8.701 0.43 0.055 0.243 
Ferricyanide 18.417 0.91 0.228 0.478 
SNP 20.268 1.00 0.069 0.292 
*To consider any peak is pure, purity angle should be less than purity threshold 
 
Base degradation 
Into a 10 ml volumetric flask containing 2 ml of SNP injection, 1 ml of 1 
mol sodium hydroxide was added and the solution was kept at room 
temperature for 1 h. The degraded sample was neutralized with 1 ml 
of 1 mol hydrochloric acid, made up to 10 ml mark with diluent and 
chromatographed. The resultant chromatogram was given in fig. 8. 
Oxidative degradation 
Into a 10 ml volumetric flask containing 2 ml of SNP injection, 1 ml 
of 30% hydrogen peroxide was added and the solution was kept at 
room temperature for 2 h. The degraded sample was made up to 10 
ml mark with diluent and chromatographed. The resultant 
chromatogram is given in fig. 9. 
Thermal degradation 
The SNP injection sample is kept in a hot air oven at 85 °C for 72 h. 
After attaining the room, temperature sample was prepared as per 
the test method by taking 2 ml of thermal degradation sample and 
chromatographed. The resultant chromatogram is given in fig. 10. 
Photolytic degradation  
The SNP injection sample was kept in the photolytic chamber and 
exposed to white fluorescent light, 1.2 million Lux hours and UV 
light 200-watt hours/square meter. After attaining room, 
temperature the sample was prepared as per the test method by 
taking 2 ml of photolytic degradation sample and chromatographed. 
The resultant chromatogram was given in fig. 11. 
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Fig. 7: Acid degradation chromatogram of SNP injection formulation 
 
 
Fig. 8: Base degradation chromatogram of SNP injection formulation 
 
 
Fig. 9: Oxidative degradation chromatogram of SNP injection formulation 
 
 
Fig. 10: Thermal degradation chromatogram of SNP injection formulation 
 
 
Fig. 11: Photolytic degradation chromatogram of SNP injection formulation 
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Table 6: Peak purity results of SNP from degradation samples 
Degradation Area of SNP % of degradation Peak purity of SNP 
Purity angle Purity threshold 
Control sample 35895014 NA 0.106 0.303 
Acid degradation 35932047 Nil 0.022 0.303 
Base degradation 30010842 16.4 0.027 0.284 
Peroxide degradation 35471819 1.2 0.027 0.314 
Thermal degradation 34400144 4.2 0.105 0.393 
Photolytic degradation 32324418 10.5 0.075 0.282 
 
Precision 
The precision of an analytical method expresses the closeness of 
agreement between a series of injections prepared from a single 
homogenized stock solution. It indicates the reproducible capability 
of an analytical method.  
Method precision was evaluated by preparing six different spiked 
samples on the same day, and intermediate precision was evaluated by 
preparing six different spiked samples on a different day. Each precision 
sample was prepared by spiking known impurities at a 0.5% level to SNP 
injection formulation and chromatographed as per the proposed 
method. The obtained precision results were given in table 7. 
  
Table 7: Results from both method precision and intermediate precision. 
Preparation Nitrite Nitrate Ferrocyanide Ferricyanide 
Method precision (n=6)* 
Mean (%w/v) 0.505 0.493 0.495 0.525 
SD 0.0008 0.0008 0.0015 0.0008 
%RSD 0.2 0.2 0.4 0.2 
Intermediate precision (n=6)* 
Mean (%w/v) 0.495 0.491 0.493 0.512 
SD 0.0021 0.0025 0.0021 0.0015 
%RSD 0.04 0.4 0.4 0.2 
Cumulative precision (n=12)# 
Mean (%w/v) 0.500 0.492 0.494 0.519 
SD 0.0056 0.0020 0.0023 0.0069 
%RSD 1.1 0.4 0.5 1.3 
*Number of experiments done (n):6, #Number of experiments done (n):12 (cumulative results of both precision and intermediate precision) 
 
Linearity and sensitivity  
The linearity of an analytical method indicates its ability to obtain 
test results which are directly proportional to the concentration in a 
specific range. Linearity was performed for all four known 
impurities and SNP from 0.05 µg/ml to 38 µg/ml. Linearity solutions 
were evaluated by linear regression analysis and calculated by the 
least square method and studied. Limit of detection (LOD) and Limit 
of quantification (LOQ) results for four known impurities and the 
SNP were calculated from linearity solutions by using the slope of 
the calibration curve. Based on the sensitivity results in six different 
preparations of known impurities and SNP were prepared at their 
LOD and LOQ to check the precision. Precision results at their lowest 
detection and quantification level were given in table 8. 
LOD = 3.3 x Standard deviation of the response/Slope of the 
calibration curve  
LOQ = 10 x Standard deviation of the response/Slope of the 
calibration curve 
 
Table 8: Linearity and sensitivity results of known impurities and SNP 
Parameter Nitrite Nitrate Ferrocyanide Ferricyanide SNP 
Range (µg/ml) 0.25-37.68 0.25-37.53 0.25-37.50 1.00-37.74 0.75-37.27 
Regression equation*  69738x+1266.5 50744x+2176.5 78543x-4930.4 23284x-5515.8 29661x-1238.2 
Correlation**  0.9999 0.9999 0.9999 0.9999 0.9999 
LOD (µg/ml) 0.084 0.083 0.083 0.332 0.248 
LOQ (µg/ml) 0.253 0.252 0.252 1.005 0.752 
LOD precision (n=6)#      
Mean area 7132 4334 6150 6781 7424 
%RSD 1.5 0.8 1.6 2.7 2.2 
LOQ precision (n=6)#     
Mean area 18925 13423 19325 21378 22294 
%RSD 0.4 0.1 0.8 0.7 1.2 
*Y is the peak area and X is the concentration injected, **Correlation coefficient, #Number of experiments done (n):6 
 
Accuracy 
The accuracy of an analytical method indicates the closeness of 
agreement between an actual value and obtained value at a 
particular range. Accuracy for all known impurities was evaluated at 
levels LOQ, 50%, 100%, and 150% by spiking to the SNP injection 
formulation. At each level, triplicate solutions were prepared by 
spiking individual impurities from their respective stock solutions 
and chromatographed. Accuracy results for known impurities were 
given in table 9 and 10. 
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Table 9: Accuracy results of known impurities at their minimum quantification level (LOQ) 
Component Amount added (%w/w) Amount found (%w/w) % recovery  Mean recovery SD* % RSD 
 n=3# 
 0.0051 0.0058 113.7    
Nitrite 0.0051 0.0058 113.7 113.7 0.000 0.0 
 0.0051 0.0058 113.7    
 0.0051 0.0052 102.0    
Nitrate 0.0051 0.0053 103.9 102.6 1.096 1.1 
 0.0051 0.0052 102.0    
 0.0051 0.0051 100.0    
Ferrocyanide 0.0051 0.0050 98.0 98.7 1.154 1.1 
 0.0051 0.0050 98.0    
 0.0198 0.0199 100.5    
Ferricyanide 0.0198 0.0197 99.5 100.2 0.577 0.6 
 0.0198 0.0199 100.5    
*Standard deviation, #Number of experiments done (n):3 
 









% RSD±SD % of recovery % RSD±SD 
 n=3# n=9# 
Nitrite 
50% 0.253 0.256 101.2 0.0±0.000   
100% 0.506 0.505 99.7 0.1±0.115 100.5 0.6±0.638 
150% 0.759 0.763 100.5 0.1±0.057   
Nitrate 
50% 0.251 0.251 100.0 0.0±0.000   
100% 0.503 0.493 97.9 0.1±0.115 98.7 1.0±0.961 
150% 0.754 0.741 98.3 0.2±0.173   
Ferrocyanide 
50% 0.251 0.249 99.2 0.0±0.000   
100% 0.503 0.495 98.4 0.2±0.200 99.5 1.1±1.048 
150% 0.754 0.760 100.8 0.1±0.058   
Ferricyanide 
50% 0.253 0.266 105.0 0.6±0.611   
100% 0.506 0.525 103.7 0.1±0115 104.4 0.6±0.621 
150% 0.758 0.792 104.5 0.1±0.058   
# Number of experiments done at each level (n):3, cumulative recovery for all three levels (n):9 
 
Robustness 
Robustness of the analytical method was evaluated by deliberately 
altering some of the critical method parameters to check the method 
capability on system suitability results and provides an indication of 
its reliability during normal usage. Robustness was checked for flow 
rate (±10%), column oven temperature (±5 °C), pH of the buffer 
(±0.2 units), organic composition in the mobile phase (±2% 
absolute), and wavelength (±5 nm). The obtained robustness results 
were given in table 11 to 15. 
 
Table 11: Robustness impact on nitrite peak from system suitability solution 
Parameter Variation RRT USP tailing USP plate count 
Control  - 0.19 1.2 11172 
Flow rate (±10%) 0.72 ml/min 0.19 1.2 11686 
0.88 ml/min 0.19 1.2 10654 
Column oven temperature(±5 °C) 25 °C 0.18 1.2 10593 
35 °C 0.21 1.2 11425 
Buffer pH (±0.2 units) 8.4 0.18 1.2 11346 
8.8 0.18 1.2 11397 
Mobile phase composition (±2%) 67:33 0.15 1.2 11637 
63:37 0.22 1.2 10726 
Wave length (±5 nm) 215 nm 0.19 1.2 11168 
225 nm 0.19 1.2 11185 
 
Table 12: Robustness impact on nitrate peak from system suitability solution 
Parameter Variation RRT Resolution* USP Tailing USP plate count 
Control  - 0.23 5.0 1.2 13163 
Flow rate (±10%) 0.72 ml/min 0.23 5.0 1.2 13258 
0.88 ml/min 0.23 4.8 1.2 12415 
Column oven 
temperature(±5 °C) 
25 °C 0.21 5.2 1.2 11759 
35 °C 0.25 4.6 1.2 12966 
Buffer pH (±0.2 units) 8.4 0.22 4.9 1.2 10949 
8.8 0.22 4.9 1.2 11513 
Mobile phase composition 
(±2%) 
67:33 0.18 5.6 1.2 13876 
63:37 0.26 4.1 1.3 7933 
Wave length (±5 nm) 215 nm 0.23 4.9 1.2 13094 
225 nm 0.23 4.9 1.2 13151 
*Resolution between nitrite and nitrate 
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Table 13: Robustness impact on ferrocyanide peak from system suitability solution 
Parameter Variation RRT USP Tailing USP plate count 
Control  - 0.43 1.1 9739 
Flow rate (±10%) 0.72 ml/min 0.43 1.1 10401 
0.88 ml/min 0.43 1.1 9136 
Column oven temperature(±5 °C) 25 °C 0.39 1.1 8977 
35 °C 0.47 1.1 10392 
Buffer pH (±0.2 units) 8.4 0.43 1.1 10122 
8.8 0.43 1.1 9972 
Mobile phase composition (±2%) 67:33 0.42 1.1 10980 
63:37 0.44 1.1 9105 
Wave length (±5 nm) 215 nm 0.43 1.1 9667 
225 nm 0.43 1.1 9761 
 
Table 14: Robustness impact on ferricyanide peak from system suitability solution 
Parameter Variation RRT USP Tailing USP plate count 
Control  - 0.91 0.2 15500 
Flow rate (±10%) 0.72 ml/min 0.91 0.2 15611 
0.88 ml/min 0.91 0.2 14532 
Column oven temperature (±5 °C) 25 °C 0.88 0.2 14482 
35 °C 0.93 0.2 15477 
Buffer pH (±0.2 units) 8.4 0.93 0.2 14932 
8.8 0.92 0.2 15568 
Mobile phase composition (±2%) 67:33 0.94 0.2 15664 
63:37 0.91 0.2 14484 
Wave length (±5 nm) 215 nm 0.91 0.2 15060 
225 nm 0.91 0.2 15048 
 
Table 15: Robustness impact on SNP peak from system suitability solution 
Parameter Variation RRT USP Tailing USP plate count 
Control  - 1.0 1.1 18059 
Flow rate (±10%) 0.72 ml/min 1.0 1.2 18262 
0.88 ml/min 1.0 1.2 17037 
Column oven temperature(±5 °C) 25 °C 1.0 1.2 16900 
35 °C 1.0 1.1 18174 
Buffer pH (±0.2 units) 8.4 1.0 1.1 17438 
8.8 1.0 1.1 17433 
Mobile phase composition (±2%) 67:33 1.0 1.2 17974 
63:37 1.0 1.1 17589 
Wave length (±5 nm) 215 nm 1.0 1.1 17358 
225 nm 1.0 1.1 18311 
 
Solution stability 
Solution stability is necessary to assess the stability of standard and 
sample solutions during product development and stability data 
evaluation. Sample solution stability was evaluated by spiking all 
known impurities on SNP injection formulation and injected at 
different time intervals by keeping the solution at controlled room 
temperature (~25 °C). Similarly, standard solutions were injected 
periodically. The % difference in an area of each impurity and SNP 
was calculated, and the results were given in table 16, 17. 
  
Table 16: Standard solution stability results from standard-1 and 2 
Component 0 h 2 h 6 h 12 h 24 h 48 h 
Nitrite NA 0.0 0.1 0.3 0.5 1.0 
Nitrate NA 0.4 0.1 0.1 0.6 0.9 
Ferrocyanide NA 0.1 0.3 0.3 0.6 0.2 
Ferricyanide NA 1.5 2.0 2.2 2.4 1.9 
SNP  NA 0.4 0.2 0.6 1.0 1.7 
 
Table 17: Spiked sample solution stability results 
Component 0 h 2 h 6 h 12 h 24 h 48 h 
Nitrite NA 0.2 0.1 0.3 0.8 1.2 
Nitrate NA 0.2 0.1 0.3 0.9 1.4 
Ferrocyanide NA 0.6 1.2 1.6 1.3 1.3 
Ferricyanide NA 0.6 1.8 2.9 4.3 4.1 
SNP  NA 0.1 0.1 0.1 0.7 1.0 
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CONCLUSION 
A simple RP-HPLC method for quantification of known impurities 
and other possible degradation impurities in the SNP injectable 
formulation was successfully developed and validated. The 
proposed methodology is specific, precise, rugged, linear, accurate, 
stable, and robust for the quantification of related impurities of SNP 
injection. Moreover, the developed method has the lowest detectable 
and quantification capability. The degradation data shows, the SNP 
is sensitive to photolytic and base hydrolysis, moderately sensitive 
to thermal oxidation, and stable in acid hydrolysis. The degradation 
impurities formed during stress study are well resolved; hence any 
degradation impurity formed during the product life cycle above the 
identification threshold could be quantified. Based on the above 
advantages, the proposed method could be useful for monitoring 
possible degradation impurities of SNP in its injectable formulation 
in quality control departments of manufacturing units. 
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